Vertex, Cystic Fibrosis Foundation deal

VRTX will receive $13.3 million from Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the drug discovery arm of the foundation, to support development of VX-770 to treat cystic fibrosis (CF) thr...